COVID-19 Impact on Anti-Viral Drugs Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Anti-Viral Drugs Industry
1.7 COVID-19 Impact: Anti-Viral Drugs Market Trends
2 Global Anti-Viral Drugs Quarterly Market Size Analysis
2.1 Anti-Viral Drugs Business Impact Assessment - COVID-19
2.1.1 Global Anti-Viral Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Anti-Viral Drugs Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Anti-Viral Drugs Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Anti-Viral Drugs Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Anti-Viral Drugs Factory Price by Manufacturers
3.3 Location of Key Manufacturers Anti-Viral Drugs Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Anti-Viral Drugs Market
3.5 Key Manufacturers Anti-Viral Drugs Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Anti-Viral Drugs Segments, By Type
4.1 Introduction
1.4.1 Nucleotide Polymerase Inhibitor
1.4.2 Reverse Transcriptase Inhibitor
1.4.3 Protease Inhibitor
4.2 By Type, Global Anti-Viral Drugs Market Size, 2019-2021
4.2.1 By Type, Global Anti-Viral Drugs Market Size by Type, 2020-2021
4.2.2 By Type, Global Anti-Viral Drugs Price, 2020-2021
5 Impact of Covid-19 on Anti-Viral Drugs Segments, By Application
5.1 Overview
5.5.1 HIV
5.5.2 Hepatitis
5.5.3 HSV
5.5.4 Influenza
5.2 By Application, Global Anti-Viral Drugs Market Size, 2019-2021
5.2.1 By Application, Global Anti-Viral Drugs Market Size by Application, 2019-2021
5.2.2 By Application, Global Anti-Viral Drugs Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 F. Hoffmann-La Roche
7.1.1 F. Hoffmann-La Roche Business Overview
7.1.2 F. Hoffmann-La Roche Anti-Viral Drugs Quarterly Production and Revenue, 2020
7.1.3 F. Hoffmann-La Roche Anti-Viral Drugs Product Introduction
7.1.4 F. Hoffmann-La Roche Response to COVID-19 and Related Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Business Overview
7.2.2 GlaxoSmithKline Anti-Viral Drugs Quarterly Production and Revenue, 2020
7.2.3 GlaxoSmithKline Anti-Viral Drugs Product Introduction
7.2.4 GlaxoSmithKline Response to COVID-19 and Related Developments
7.3 Bristol-Myers-Squibb
7.3.1 Bristol-Myers-Squibb Business Overview
7.3.2 Bristol-Myers-Squibb Anti-Viral Drugs Quarterly Production and Revenue, 2020
7.3.3 Bristol-Myers-Squibb Anti-Viral Drugs Product Introduction
7.3.4 Bristol-Myers-Squibb Response to COVID-19 and Related Developments
7.4 AbbVie
7.4.1 AbbVie Business Overview
7.4.2 AbbVie Anti-Viral Drugs Quarterly Production and Revenue, 2020
7.4.3 AbbVie Anti-Viral Drugs Product Introduction
7.4.4 AbbVie Response to COVID-19 and Related Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Business Overview
7.5.2 Johnson & Johnson Anti-Viral Drugs Quarterly Production and Revenue, 2020
7.5.3 Johnson & Johnson Anti-Viral Drugs Product Introduction
7.5.4 Johnson & Johnson Response to COVID-19 and Related Developments
7.6 Merck & Co
7.6.1 Merck & Co Business Overview
7.6.2 Merck & Co Anti-Viral Drugs Quarterly Production and Revenue, 2020
7.6.3 Merck & Co Anti-Viral Drugs Product Introduction
7.6.4 Merck & Co Response to COVID-19 and Related Developments
7.7 Aurobindo Pharma
7.7.1 Aurobindo Pharma Business Overview
7.7.2 Aurobindo Pharma Anti-Viral Drugs Quarterly Production and Revenue, 2020
7.7.3 Aurobindo Pharma Anti-Viral Drugs Product Introduction
7.7.4 Aurobindo Pharma Response to COVID-19 and Related Developments
7.8 Cipla
7.8.1 Cipla Business Overview
7.8.2 Cipla Anti-Viral Drugs Quarterly Production and Revenue, 2020
7.8.3 Cipla Anti-Viral Drugs Product Introduction
7.8.4 Cipla Response to COVID-19 and Related Developments
7.9 Dr Reddy's
7.9.1 Dr Reddy's Business Overview
7.9.2 Dr Reddy's Anti-Viral Drugs Quarterly Production and Revenue, 2020
7.9.3 Dr Reddy's Anti-Viral Drugs Product Introduction
7.9.4 Dr Reddy's Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Anti-Viral Drugs Supply Chain Analysis
8.1.1 Anti-Viral Drugs Supply Chain Analysis
8.1.2 Covid-19 Impact on Anti-Viral Drugs Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Anti-Viral Drugs Distribution Channels
8.2.2 Covid-19 Impact on Anti-Viral Drugs Distribution Channels
8.2.3 Anti-Viral Drugs Distributors
8.3 Anti-Viral Drugs Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Anti-Viral Drugs Assessment
Table 9. COVID-19 Impact: Anti-Viral Drugs Market Trends
Table 10. COVID-19 Impact Global Anti-Viral Drugs Market Size
Table 11. Global Anti-Viral Drugs Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Anti-Viral Drugs Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Anti-Viral Drugs Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Anti-Viral Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Anti-Viral Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Anti-Viral Drugs Market Growth Drivers
Table 17. Global Anti-Viral Drugs Market Restraints
Table 18. Global Anti-Viral Drugs Market Opportunities
Table 19. Global Anti-Viral Drugs Market Challenges
Table 20. Key Manufacturers Anti-Viral Drugs Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Anti-Viral Drugs Market Size, 2019 (K Units) & (US$ Million)
Table 22. Anti-Viral Drugs Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Anti-Viral Drugs Manufacturing Plants
Table 24. Key Manufacturers Anti-Viral Drugs Market Served
Table 25. Date of Key Manufacturers Enter into Anti-Viral Drugs Market
Table 26. Key Manufacturers Anti-Viral Drugs Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Anti-Viral Drugs Market Size by Type, 2020, (US$ Million)
Table 29. Global Anti-Viral Drugs Market Size by Type, 2020 (K Units)
Table 30. Global Anti-Viral Drugs Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Anti-Viral Drugs Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Anti-Viral Drugs Market Size by Application, 2020-2021 (K Units)
Table 33. Global Anti-Viral Drugs Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Anti-Viral Drugs Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Anti-Viral Drugs Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Anti-Viral Drugs Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Anti-Viral Drugs Market Size, 2019-2021 (K Units)
Table 38. US Anti-Viral Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Anti-Viral Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Anti-Viral Drugs Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Anti-Viral Drugs Market Size, 2019-2021 (K Units)
Table 43. Germany Anti-Viral Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Anti-Viral Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Anti-Viral Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Anti-Viral Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Anti-Viral Drugs Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Anti-Viral Drugs Market Size, 2019-2021 (K Units)
Table 50. China Anti-Viral Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Anti-Viral Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Anti-Viral Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Anti-Viral Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Anti-Viral Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Anti-Viral Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Anti-Viral Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. F. Hoffmann-La Roche Business Overview
Table 58. F. Hoffmann-La Roche Anti-Viral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. F. Hoffmann-La Roche Anti-Viral Drugs Product
Table 60. F. Hoffmann-La Roche Response to COVID-19 and Related Developments
Table 61. GlaxoSmithKline Business Overview
Table 62. GlaxoSmithKline Anti-Viral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. GlaxoSmithKline Anti-Viral Drugs Product
Table 64. GlaxoSmithKline Response to COVID-19 and Related Developments
Table 65. Bristol-Myers-Squibb Business Overview
Table 66. Bristol-Myers-Squibb Anti-Viral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Bristol-Myers-Squibb Anti-Viral Drugs Product
Table 68. Bristol-Myers-Squibb Response to COVID-19 and Related Developments
Table 69. AbbVie Business Overview
Table 70. AbbVie Anti-Viral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. AbbVie Anti-Viral Drugs Product
Table 72. AbbVie Response to COVID-19 and Related Developments
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Anti-Viral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Johnson & Johnson Anti-Viral Drugs Product
Table 76. Johnson & Johnson Response to COVID-19 and Related Developments
Table 77. Merck & Co Business Overview
Table 78. Merck & Co Anti-Viral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Merck & Co Anti-Viral Drugs Product
Table 80. Merck & Co Response to COVID-19 and Related Developments
Table 81. Aurobindo Pharma Business Overview
Table 82. Aurobindo Pharma Anti-Viral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Aurobindo Pharma Anti-Viral Drugs Product
Table 84. Aurobindo Pharma Response to COVID-19 and Related Developments
Table 85. Cipla Business Overview
Table 86. Cipla Anti-Viral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Cipla Anti-Viral Drugs Product
Table 88. Cipla Response to COVID-19 and Related Developments
Table 89. Dr Reddy's Business Overview
Table 90. Dr Reddy's Anti-Viral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Dr Reddy's Anti-Viral Drugs Product
Table 92. Dr Reddy's Response to COVID-19 and Related Developments
Table 93. Anti-Viral Drugs Distributors List
Table 94. Anti-Viral Drugs Customers List
Table 95. Covid-19 Impact on Anti-Viral Drugs Customers
List of FiguresFigure 1. Anti-Viral Drugs Product Picture
Figure 2. Anti-Viral Drugs Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Anti-Viral Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Anti-Viral Drugs Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Anti-Viral Drugs Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Anti-Viral Drugs Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Anti-Viral Drugs Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Anti-Viral Drugs Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Anti-Viral Drugs Market Size Market Share, 2019-2021